Abstract:Abstract Background Nonalcoholic fatty liver disease (NAFLD) has a multidirectional relationship with metabolic syndrome (MetS) and used to be considered a hepatic manifestation of MetS. Perirenal fat, as a part of visceral adipose tissue (VAT), was reported to be correlated with MetS components, but data for intraorgan fat are lacking. This study was undertaken to assess the value of peripheral and intraorgan fat to predict MetS in adults with overweight and obesity with suspected NAFLD. Methods We studied 134 sequential adults (mean age, 31.5 years; 47% female) with overweight and obesity with suspected NAFLD. All participants underwent abdominal magnetic resonance imaging (MRI) examination. Anthropometric and metabolic parameters and perirenal fat thickness (PRFT), subcutaneous adipose tissue thickness (SATT), liver fat fraction (LFF), pancreas fat fraction (PFF), and lumbar spine fat fraction (LSFF) were collected. MetS was defined according to the International Diabetes Federation (IDF) criteria. Statistical analyses included basic statistics, linear correlation and logistic regression analysis. Results A total of 63 adults with MetS and 71 adults with advanced liver steatosis (grades 2 and 3) were included in our study. Patients with MetS had greater PRFT (p = 0.026) and LFF (p < 0.001), as well as greater homeostasis model assessment of insulin resistance (HOMA-IR), alanine transaminase (ALT), aspartate transaminase (AST), and decreased SATT. MetS patients had a higher proportion of advanced steatosis than those without MetS (P < 0.001). The MetS score was associated with PRFT and LFF. Logistic regression analysis showed that the PRFT and LFF were independent predictors of MetS after adjusting for age and sex. A cutoff of 9.15 mm for PRFT and 14.68% for LFF could be predictive of MetS. Conclusions This study shows that the absolute cutoff level of 9.15 mm for PRFT and 14.68% for LFF may be clinically important markers for identifying patients who are at high risk of MetS among adults with overweight and obesity with suspected NAFLD, irrespective of sex and age. Moreover, ectopic fat levels in pancreas and lumbar spine are positively associated with PRFT. Trial registration Not applicable.

Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease

Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes

Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance

Relationships of Thickness of Perirenal Fat with Urinary Levels of MCP-1 and NGAL in Patients with Hypertension

The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease

Perirenal Fat Thickness Is Associated With Contrast‐Induced Nephropathy in Type 2 Diabetic Patients Undergoing Coronary Catheterization

Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients

Para-perirenal fat thickness is associated with reduced glomerular filtration rate regardless of other obesity-related indicators in patients with type 2 diabetes mellitus

Associations of Perirenal Fat Thickness with Renal and Systemic Calcified Atherosclerosis

Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study

The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications

Sonographic Evaluation of Para- and Perirenal Fat Thickness is an Independent Predictor of Early Kidney Damage in Obese Patients

Perirenal Fat Thickness Contributes to the Estimated 10-Year Risk of Cardiovascular Disease and Atherosclerotic Cardiovascular Disease in Type 2 Diabetes Mellitus

Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease

Renal sinus fat is associated with intrarenal hemodynamic abnormalities independent of visceral fat in patients with chronic kidney disease

High Perirenal Fat Thickness Predicts a Poor Progression-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma.

Perirenal Fat Thickness and Liver Fat Fraction Are Independent Predictors of MetS in Adults with Overweight and Obesity Suspected with NAFLD: a Retrospective Study

Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes

Association between incidental perirenal fat stranding on CT and metabolic syndrome in otherwise healthy adults

Perirenal Fat Associated With High-Grade Renal Cell Carcinoma In Chinese Patients

Risk Factors Influencing the Thickness and Stranding of Perinephric Fat of Mayo Adhesive Probability Score in Minimally Invasive Nephrectomy